Skip to Main Content
Legislation Search

H.R. 4606: Ally’s Act

This bill, known as Ally's Act, aims to amend several existing laws related to health insurance to ensure broader coverage for hearing devices and associated services. Here is a breakdown of its key provisions:

Coverage Requirements

The bill requires that group health plans and health insurance issuers, whether for employers or for individual policyholders, must provide coverage for several specific items and services related to hearing devices. These include:

  • Auditory implant devices, including cochlear implants and bone conduction implants.
  • Maintenance and repair of these auditory devices.
  • Upgrades or replacements of these devices every five years, if an upgrade is not available.
  • Accompanying items like adhesive adapters and softband headbands.
  • A comprehensive hearing assessment.
  • Preoperative and postoperative assessments related to surgery for the devices.
  • Aural rehabilitation and treatment services as deemed necessary by a medical professional.

Coverage Conditions

Any health plan providing coverage for these services must ensure that:

  • The financial implications (like copayments or deductibles) for hearing devices are no more restrictive than those for general medical and surgical benefits.
  • There aren’t separate treatment limits for hearing device services that are stricter than those for other covered benefits.
  • If a qualified physician or audiologist deems the services medically necessary, the insurance cannot deny or limit coverage for those services.

Definitions

The bill also provides a definition for "qualifying individuals," specifying that they are those for whom a physician or qualified audiologist determines may benefit from the auditory devices mentioned in the bill.

Applicable Laws

The bill modifies the following laws to include the new coverage requirements:

  • Public Health Service Act
  • Employee Retirement Income Security Act (ERISA)
  • Internal Revenue Code
  • Patient Protection and Affordable Care Act

Effective Date

The changes proposed by this legislation would become effective for plan years starting on or after January 1, 2026.

Relevant Companies

  • PHG (Royal Philips) - A major manufacturer of hearing aids and auditory implant devices, likely to see increased demand for its products under this expanded coverage.
  • WSO (Walmart Inc.) - As a retailer that offers health services, Walmart may benefit from expanded coverage options and the sale of hearing devices.
  • DEO (DeVry University) - Involved in audiology training and services, may see increased enrollment in programs due to a growing need for audiologists as coverage expands.

This is an AI-generated summary of the bill text. There may be mistakes.

Show More

Sponsors

4 bill sponsors

Actions

2 actions

Date Action
Jul. 22, 2025 Introduced in House
Jul. 22, 2025 Referred to the Committee on Energy and Commerce, and in addition to the Committees on Education and Workforce, and Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

Corporate Lobbying

0 companies lobbying

None found.

* Note that there can be significant delays in lobbying disclosures, and our data may be incomplete.

Potentially Relevant Congressional Stock Trades

Estimated excess return of the underlying stock since the transaction
Politician Stock Transaction Filed Traded
Congress pfp
George Whitesides D / House
DEO logo
DEO STOCK, COMPANY-SPECIFIC HOLDINGS INTO PASSIVE ETFS AND MUTUAL FUNDS, PER BEST PRACTICES. C�������: TO AVOID ANY POSSIBLE CONFLICTS OF INTEREST WITH MY FUTURE CONGRESSIONAL WORK, I’M TRANSITIONING MY SINGLE STOCK, COMPANY-SPECIFIC HOLDINGS INTO PASSIVE ETFS AND MUTUAL FUNDS, PER BEST PRACTICES. DIAGEO PLC COMMON STOCK
Sale $15,001 - $50,000
Apr 23, 2025 Mar 24, 2025 -16.17%
Congress pfp
Kelly Morrison D / House
DEO logo
DEO DIAGEO PLC COMMON STOCK
Sale $1,001 - $15,000
Apr 11, 2025 Mar 20, 2025 -19.63%
Congress pfp
Kelly Morrison D / House
DEO logo
DEO DIAGEO PLC COMMON STOCK
Sale $1,001 - $15,000
Apr 11, 2025 Mar 20, 2025 -19.63%
Congress pfp
Kelly Morrison D / House
DEO logo
DEO DIAGEO PLC COMMON STOCK
Sale $1,001 - $15,000
Apr 11, 2025 Mar 20, 2025 -19.63%
Congress pfp
Josh Gottheimer D / House
DEO logo
DEO DIAGEO PLC COMMON STOCK
Sale $1,001 - $15,000
Apr 10, 2025 Mar 19, 2025 -18.05%
Congress pfp
Tommy Tuberville R / Senate
DEO logo
DEO Diageo Plc ADR
Sale (Full) $15,001 - $50,000
Feb 14, 2025 Jan 10, 2025 -24.60%
Congress pfp
John James R / House
DEO logo
DEO DIAGEO PLC COMMON STOCK
Sale $1,001 - $15,000
Sep 06, 2024 Sep 04, 2024 -37.56%
Congress pfp
Ro Khanna D / House
DEO logo
DEO DC DIAGEO ADR
Sale $1,001 - $15,000
Jul 08, 2024 Jun 26, 2024 -37.90%
Congress pfp
Ro Khanna D / House
DEO logo
DEO DIAGEO ADR
Sale $1,001 - $15,000
Jul 08, 2024 Jun 26, 2024 -37.90%
Congress pfp
Ro Khanna D / House
DEO logo
DEO DIAGEO ADR
Sale $1,001 - $15,000
Jul 08, 2024 Jun 26, 2024 -37.90%
Congress pfp
Josh Gottheimer D / House
DEO logo
DEO DIAGEO PLC COMMON STOCK
Sale $1,001 - $15,000
Jul 09, 2024 Jun 18, 2024 -38.00%
Congress pfp
Sheldon Whitehouse D / Senate
DEO logo
DEO Diageo Plc ADR
Sale (Full) $15,001 - $50,000
Jun 06, 2024 May 08, 2024 -51.03%
Congress pfp
John James R / House
DEO logo
DEO DIAGEO PLC COMMON STOCK
Purchase $1,001 - $15,000
Sep 02, 2024 Mar 05, 2024 -57.20%
Congress pfp
Earl Blumenauer D / House
PHG logo
PHG KONINKLIJKE PHILIPS N.V. NY REGISTRY SHARES
Purchase $1,001 - $15,000
Mar 02, 2024 Feb 12, 2024 +14.02%
Congress pfp
Earl Blumenauer D / House
DEO logo
DEO DIAGEO PLC
Purchase $15,001 - $50,000
Jan 04, 2024 Dec 07, 2023 -66.34%
Congress pfp
Lois Frankel D / House
DEO logo
DEO DIAGEO PLC
Sale $1,001 - $15,000
Oct 10, 2023 Sep 08, 2023 -79.19%
Congress pfp
Lois Frankel D / House
WSO logo
WSO WATSCO, INC.
Sale $1,001 - $15,000
Oct 10, 2023 Sep 08, 2023 -15.16%